• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AAOS and OREF Announce Strategic Partnership

Share:

May 11, 2020

The American Academy of Orthopaedic Surgeons (AAOS) and the Orthopaedic Research and Education Foundation (OREF) announced a strategic partnership to help narrow the gap between clinical research funding and prioritized clinical research needs in musculoskeletal care. The partnership aims to highlight areas of clinical research for which there is a need for increased, targeted funding to evaluate the effectiveness of various orthopaedic interventions and ultimately improve the quality of care for patients.

“Orthopaedic surgeons rely on the AAOS clinical practice guidelines to provide high-quality, unbiased evidence-based recommendations for a variety of musculoskeletal treatments. However, there are several orthopaedic interventions for which there is a dearth of evidence evaluating their effectiveness,” said Kristy Weber, MD, FAAOS, AAOS past president. “Together with our partners at OREF, we have designed a unique funding opportunity for clinical researchers looking to design and execute studies across musculoskeletal specialties­­, including orthobiologics. To help jump-start the effort in 2020, the AAOS is making an initial financial investment.”

The inaugural list of clinical research topics prioritized by the AAOS includes research addressing the efficacy of biologics for treatment of orthopaedic diseases with a particular focus on platelet rich plasma and growth factor injections for full-thickness rotator cuff tears and osteoarthritis of the knee. Additionally, the AAOS has prioritized funding for clinical research reviewing the effect of tobacco, vaping, and/or marijuana use on postoperative outcomes for total joint arthroplasty, as well as the effectiveness of antibiotic bone cement for prevention of periprosthetic joint infections. The OREF Research Grants Committee will finalize the selection of topics in the Request for Applications (RFA) scheduled to be released later this year.

“OREF was founded on the belief that to advance orthopaedic practice, we must advance orthopaedic knowledge,” said Richard F. Kyle, MD, OREF president. “We are delighted to collaborate with the AAOS to fund investigational grants that will catalyze research and play a key role in the future of orthopaedic care.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

For more information about the AAOS’ quality programs and guidelines, including the AAOS’ recent investment in evidence-based educational content and symposia for orthobiologics, visit AAOS.org/quality. Donors interested in earmarking funds to further enable AAOS-prioritized clinical research needs within musculoskeletal healthcare can contribute to the OREF/AAOS Clinical Research Gaps Fund. Go to oref.org/aaoscpg to make a secure online donation.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Grifols Completes the Acquisition of Biotest: a Strategic and Transformational Transaction to Accelerate Growth and InnovationGrifols Completes the Acquisition of Biotest: a Strategic and Transformational Transaction to Accelerate Growth and Innovation
  • Philips, Humana Partner on 2 Pilot Programs to Improve Care for At-Risk Medicare Advantage MembersPhilips, Humana Partner on 2 Pilot Programs to Improve Care for At-Risk Medicare Advantage Members
  • Gnosis By Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharmaGnosis By Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharma
  • Propeller Health, Novartis Co-Package Asthma Medication in Europe for PrescriptionPropeller Health, Novartis Co-Package Asthma Medication in Europe for Prescription
  • Anlon Healthcare Acquires Bizotic Lifescience LimitedAnlon Healthcare Acquires Bizotic Lifescience Limited
  • Catasys Inks Deal With Goldman Sachs For $45M In Debt FinancingCatasys Inks Deal With Goldman Sachs For $45M In Debt Financing
  • Neurogene and Neoleukin Announce Definitive Merger AgreementNeurogene and Neoleukin Announce Definitive Merger Agreement
  • SSIVIX Lab Rolls Out One-Stop MyCLNQ Digital Health App To Meet Healthcare Needs DigitallySSIVIX Lab Rolls Out One-Stop MyCLNQ Digital Health App To Meet Healthcare Needs Digitally

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications